pharmaceutical post operational activities
DESCRIPTION
A SEMINAR ON Pharmaceutical post operational activities PRESENTED BY Mr. Alhat M.V. M. Pharm.(Q.A.T.) 1st SEM., Roll no. 01 GUIDED BY Prof. Mr. S. A. Hapase Q.A.T. Department P.D.V.V.P.F’s COLLEGE OF PHARMACY, VILAD GHAT, AHMEDNAGAR. Pharmaceutical Post-operational ActivitiesTRANSCRIPT
PHARMACEUTICAL POST
OPERATIONAL ACTIVITIES
By- Mr. Sagar M. Mhaske
Pharmaceutical Post-operational Activities 2
A SEMINAR ONPharmaceutical post operational activities
PRESENTED BY Mr. Alhat M.V.
M. Pharm.(Q.A.T.) 1st SEM., Roll no. 01
GUIDED BY Prof. Mr. S. A. Hapase Q.A.T. Department
P.D.V.V.P.F’s COLLEGE OF PHARMACY, VILAD GHAT, AHMEDNAGAR.
Pharmaceutical Post-operational Activities 3
MARKET COMPLAINT
Pharmaceutical Post-operational Activities 4
DEFINITION: Complaint is defined as any written,
electronic, or oral communication that alleges deficiencies related to the identity, quality, durability, reliability, safety, effectiveness, or performance device after it is released for distribution.
Pharmaceutical Post-operational Activities 5
OBJECTIVES: To identify the key issues in
product complaint and recall handling.
To understand the specific requirements for organization, procedures and resources.
To understand and develop actions to resolve current issues applicable to you.
Pharmaceutical Post-operational Activities 6
RESPONSIBILITY: Company employees, representatives
and distributors are responsible for reporting all customer complaints to Customer Service or local Customer Action Report (CAR) Coordinator.
The QA/QC Manager is responsible for determining whether a complaint requires review by Material Review Board.
Assigned complaint investigators are responsible for completing and documenting the investigation in a timely manner.
Pharmaceutical Post-operational Activities 7
Document Control is responsible for the retention of all original complaint records and reports.
Continued…
Pharmaceutical Post-operational Activities 8
TYPES OF COMPLAINT: Reagent problem Device problem Hardware problem Software problem Packaging problem Labeling / procedural problem Service problem Processing problem Operator Error
Pharmaceutical Post-operational Activities 9
COMPLAINT SOURCES:Complaints may be received from- Customers by letter, credit memo,
returned goods form, or phone; A manufacturer’s representative, or
other employees; A service or repair request; Journal articles; The FDA
Pharmaceutical Post-operational Activities 10
MARKET COMPLAINT HANDLING
Pharmaceutical Post-operational Activities 11
PROCEDURE:Step I: Receiving complaints
Step II: Technical Investigation
Step IV: Monthly report & trend analysis
Pharmaceutical Post-operational Activities 12
Step 1: Receiving complaints
CUSTOMER
COMPANY’S CONTACT PERSON
QACOMPLAINT
OFFICER
Make a complaint through toll-free no., e- mails, P. O. Box• Open the investigation
form, including information about the customer and information about the complaint.• Ask the customer to return the product to the company for analysis
Pharmaceutical Post-operational Activities 13
Step 2: Technical Investigation
Start the investigation
DOCUMENTATION- BASED
LABORATORY ANALYSIS
QA COMPLAINT OFFICER
Pharmaceutical Post-operational Activities 14
CONFIRMED COMPLAINTS
NON CONFIRMED COMPLAINTS
COUNTERFEIT/ TAMPERSUSPICION
step 3: corrective actions and feedback to customers
CORRECTIVE ACTIONS
FEEDBACK TO THE CUSTOMER
Step 4: Monthly reports and trend analysis
15
COMPLAINT RECORDS: Sequential number of complaints Origin of the complaint Customer information Product information Any corrective actions already taken Details of the complaint Dates, signatures, assignments, etc Instructions Investigations Analyses Conclusions Corrective actions with respect to product &
to the consumerPharmaceutical Post-operational Activities
Pharmaceutical Post-operational Activities 16
PRODUCT RECALL
Pharmaceutical Post-operational Activities 17
DEFINITION: A recall is defined as the Company’s
removal of a marketed product because of design or production defects that may compromise safety, efficacy and purity of the product or because of Government regulation.
Pharmaceutical Post-operational Activities 18
OBJECTIVES: Stop the distribution and sale of the
hazardous and unsafe products and minimize the risk of injury or death to the consumer.
Inform the public and the appropriate authorities of the problem.
Effectively and efficiently remove potentially unsafe product from the market place.
Minimize the cost and inconvenience to consumers and the industries.
Minimize the need for involving the relevant Government department and agencies by voluntary complying with the low.
Pharmaceutical Post-operational Activities 19
PURPOSE: To withdraw the product from the market
this will or may cause injury or death to person.
To withdraw the product from the market in respect of which there is a prescribe consumer product standard and the goods do not comply with the standard.
To withdraw the product from the market when there is notice in the National Gazette declaring the goods to be hazardous and unsafe.
Pharmaceutical Post-operational Activities 20
TYPES OF RECALL:•Action: Recall letter to all distribution points plus media release.
Type A
•Action: Recall letter to all distribution points.Type B
•Action: Specific telephone calls, recall letters to/representatives calling at distribution points if known where the medicines have been distributed.
Type C
Pharmaceutical Post-operational Activities 21
CLASSIFICATION OF RECALL:
•For defective/dangerous/potentially life threatening medicines
Class I
•For medicines that possibly could cause temporary or medically reversible adverse health problem or mistreatment.Class II
•For medicine that is defective and is unlikely to cause any adverse health reaction or which do not comply with the requirements of printed packaging material, product specification, labelling, etc.
Class III
Pharmaceutical Post-operational Activities 22
REASONS: Serious reports of adverse drug
reactions not included in the package insert
Unexpected frequency of adverse reaction stated in the package insert
Incorrect labeling of a product Incorrect formulation of a product Result of ongoing stability studies
(unfavorable?) Detection of GMP failure after release.
Pharmaceutical Post-operational Activities 23
Detection of GMP Failure-The photo shows an active tablet in the row of placebos in a bi-phasic oral Contraceptive blister pack
Pharmaceutical Post-operational Activities 24
BASIC INFORMATION FOR RECALL: Name, strength, pack size, batch/lot
number and any means of identification. Total quantity of the product being
recalled originally in possession of the company.
The date of distribution. The total quantity of the product actually
recalled which is already distributed. Area of distribution. List of customers.
Pharmaceutical Post-operational Activities 25
The quantity of the recalled product still in their possession.
The reason for initiating the recall; nature of defect
Suggested action to be taken and its urgency
Indication of the health risk together with reasons
Continued…
Pharmaceutical Post-operational Activities 26
RECALL STRATEGY:In formulating a recall strategy, the
followingshould be taken into consideration: Result of health hazard evaluation Ease in identifying the product Extent to which the product
deficiency is obvious to the consumer/user
Continued availability of essential products (risk: benefit)
Pharmaceutical Post-operational Activities 27
PRODUCT RECALL NOTIFICATION: Public notification Media release Publicity material Contents of notification:1. It should be brief and to the point.2. Name the product, strength, pack
size 3. Indicate nature of the defect4. Specify urgency of the action5. Indicate reason for the action6. Indicate the health risk
Pharmaceutical Post-operational Activities 28
PROCEDURE:Head QA & QC will- Investigate the market complaints,
stability failure to evaluate the risk assessment.
Decide the type of recall in consultation with recall committee.
Communicate the decision of product recall with product details to Director – Operations / Distribution Manager / Contract Giver / Principal Company and Chief Executive Officer for information.
Pharmaceutical Post-operational Activities 29
POST RECALL PROCEDURE: The report to contain the following
information: Name of the product Strength of the product Pack size Batch/ lot number Nature of the defect Action that was taken Urgency of the action taken Reason for the action
Pharmaceutical Post-operational Activities 30
Indication of the health risk and reported clinical problems
Copies of all the recall correspondence;
And Steps taken to prevent re-occurrence of the problem
After termination of a recall and not later than 90 days after a recall has been instituted, a full reconciliation must be submitted.
Continued…
Pharmaceutical Post-operational Activities 31
REFERENCE:
Pharmaceutical Post-operational Activities 32
Thank you!!!